Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising
SB 987 modifies Maryland corporate income tax treatment for direct-to-consumer pharmaceutical advertising expenses, affecting tax deductions for drug marketing costs.